John C. Clapham

6.1k total citations · 1 hit paper
72 papers, 4.3k citations indexed

About

John C. Clapham is a scholar working on Molecular Biology, Physiology and Endocrine and Autonomic Systems. According to data from OpenAlex, John C. Clapham has authored 72 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 32 papers in Physiology and 16 papers in Endocrine and Autonomic Systems. Recurrent topics in John C. Clapham's work include Adipose Tissue and Metabolism (29 papers), Regulation of Appetite and Obesity (15 papers) and Peroxisome Proliferator-Activated Receptors (10 papers). John C. Clapham is often cited by papers focused on Adipose Tissue and Metabolism (29 papers), Regulation of Appetite and Obesity (15 papers) and Peroxisome Proliferator-Activated Receptors (10 papers). John C. Clapham collaborates with scholars based in United Kingdom, Sweden and United States. John C. Clapham's co-authors include Susana Cadenas, Martin D. Brand, Mika B. Jekabsons, Karim S. Echtay, James A. Harper, Alastair Morrison, Julie St‐Pierre, Susan J. Pickering, Damien Roussel and Jeffrey A. Stuart and has published in prestigious journals such as Nature, Journal of Biological Chemistry and The Journal of Physiology.

In The Last Decade

John C. Clapham

71 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Superoxide activates mitochondrial uncoupling proteins

2002 1.1k citations Karim S. Echtay, Damien Roussel et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John C. Clapham United Kingdom	30	2.1k	1.9k	742	517	402	72	4.3k
Pavlos Pissios United States	27	1.9k 0.9×	1.4k 0.7×	1.1k 1.5×	616 1.2×	177 0.4×	36	4.3k
Dalan R. Jensen United States	22	1.2k 0.6×	2.3k 1.2×	1.9k 2.6×	687 1.3×	218 0.5×	31	4.8k
Jia Yu China	27	1.7k 0.8×	852 0.4×	956 1.3×	308 0.6×	464 1.2×	93	4.2k
Alessandra Valerio Italy	34	2.3k 1.1×	2.6k 1.4×	338 0.5×	760 1.5×	418 1.0×	97	5.6k
André Kleinridders Germany	34	2.2k 1.0×	2.2k 1.1×	992 1.3×	956 1.8×	366 0.9×	57	5.6k
Robin E. Buckingham United Kingdom	33	2.0k 0.9×	1.2k 0.6×	1.4k 1.9×	504 1.0×	122 0.3×	62	4.8k
Christoph Buettner United States	38	1.7k 0.8×	2.3k 1.2×	1.1k 1.4×	970 1.9×	281 0.7×	68	5.8k
Takashi Shimazu Japan	42	1.2k 0.6×	2.3k 1.2×	2.1k 2.8×	676 1.3×	306 0.8×	123	5.5k
Ann Petro United States	27	1.3k 0.6×	1.1k 0.6×	421 0.6×	406 0.8×	244 0.6×	40	2.9k
Johan Fernø Norway	36	1.0k 0.5×	1.6k 0.8×	973 1.3×	703 1.4×	191 0.5×	80	3.5k

Countries citing papers authored by John C. Clapham

Since Specialization

Citations

This map shows the geographic impact of John C. Clapham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John C. Clapham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John C. Clapham more than expected).

Fields of papers citing papers by John C. Clapham

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John C. Clapham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John C. Clapham. The network helps show where John C. Clapham may publish in the future.

Co-authorship network of co-authors of John C. Clapham

This figure shows the co-authorship network connecting the top 25 collaborators of John C. Clapham. A scholar is included among the top collaborators of John C. Clapham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John C. Clapham. John C. Clapham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Russo, Carla, et al.. (2020). Effects of Salvia officinalis L. and Chamaemelum nobile (L.) extracts on inflammatory responses in two models of human cells: Primary subcutaneous adipocytes and neuroblastoma cell line (SK-N-SH). Journal of Ethnopharmacology. 268. 113614–113614. 9 indexed citations

Clapham, John C.. (2011). Central control of thermogenesis. Neuropharmacology. 63(1). 111–123. 94 indexed citations

Hjorth, Stephan, et al.. (2010). Binding properties of antagonists to Cannabinoid receptors in intact cells. Fundamental and Clinical Pharmacology. 25(2). 200–210. 13 indexed citations

Kos, Katarina, Andrew H. Baker, Margareta Jernås, et al.. (2009). DPP‐IV inhibition enhances the antilipolytic action of NPY in human adipose tissue. Diabetes Obesity and Metabolism. 11(4). 285–292. 67 indexed citations

Balendran, Anudharan, et al.. (2009). Unravelling the complex dissociation of [³H]‐rimonabant from plated CB₁ cannabinoid receptor‐expressing cells. Fundamental and Clinical Pharmacology. 24(2). 181–187. 8 indexed citations

Greasley, Peter J. & John C. Clapham. (2006). Inverse agonism or neutral antagonism at G-protein coupled receptors: A medicinal chemistry challenge worth pursuing?. European Journal of Pharmacology. 553(1-3). 1–9. 44 indexed citations

Schrauwen, Patrick, D. Grahame Hardie, John C. Clapham, et al.. (2004). Improved glucose homeostasis in mice overexpressing human UCP3: a role for AMP-kinase?. International Journal of Obesity. 28(6). 824–828. 37 indexed citations

Clapham, John C., et al.. (2004). Glucose and fatty acid metabolism in McA-RH7777 hepatoma cells vs. rat primary hepatocytes: responsiveness to nutrient availability. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1684(1-3). 54–62. 36 indexed citations

Curtin, N. A., John C. Clapham, & C. J. Barclay. (2002). Excess recovery heat production by isolated muscles from mice overexpressing uncoupling protein‐3. The Journal of Physiology. 542(1). 231–235. 23 indexed citations

10.

Echtay, Karim S., Damien Roussel, Julie St‐Pierre, et al.. (2002). Superoxide activates mitochondrial uncoupling proteins. Nature. 415(6867). 96–99. 1148 indexed citations breakdown →

11.

Cai, Xue, Martyn L. Evans, John C. Clapham, et al.. (2002). Orexins and feeding: special occasions or everyday occurrence?. Regulatory Peptides. 104(1-3). 1–9. 29 indexed citations

12.

Clapham, John C.. (2001). Anti-obesity drugs: a critical review of current therapies and future opportunities. Pharmacology & Therapeutics. 89(1). 81–121. 83 indexed citations

13.

Cai, Xue, R Denis, Richard G. Vernon, et al.. (2001). Food restriction selectively increases hypothalamic orexin-B levels in lactating rats. Regulatory Peptides. 97(2-3). 163–168. 31 indexed citations

14.

Moore, Gary B.T., Jean Himms‐Hagen, Mary‐Ellen Harper, & John C. Clapham. (2001). Overexpression of UCP-3 in Skeletal Muscle of Mice Results in Increased Expression of Mitochondrial Thioesterase mRNA. Biochemical and Biophysical Research Communications. 283(4). 785–790. 61 indexed citations

15.

Clapham, John C., et al.. (2001). Concordant mRNA Expression of UCP-3, but Not UCP-2, with Mitochondrial Thioesterase-1 in Brown Adipose Tissue and Skeletal Muscle in db/db Diabetic Mice. Biochemical and Biophysical Research Communications. 287(5). 1058–1062. 20 indexed citations

16.

Turner, Nicholas C. & John C. Clapham. (1998). Insulin resistance, impaired glucose tolerance and non-insulin-dependent diabetes, pathologic mechanisms and treatment: Current status and therapeutic possibilities. Birkhäuser Basel eBooks. 51. 33–94. 39 indexed citations

17.

Clapham, John C. & Nicholas C. Turner. (1997). Effects of the Glucocorticoid II Receptor Antagonist Mifepristone on Hypertension in the Obese Zucker Rat. Journal of Pharmacology and Experimental Therapeutics. 282(3). 1503–1508. 20 indexed citations

18.

Cawthorne, Michael A., John C. Clapham, Simon Dunmore, et al.. (1996). The Thiazolidinedione Insulin Sensitiser, BRL 49653, Increases the Expression of PPAR-γ and aP2in Adipose Tissue of High-Fat-Fed Rats. Biochemical and Biophysical Research Communications. 229(3). 752–757. 74 indexed citations

19.

Clapham, John C., et al.. (1993). Effects of Levcromakalim and RP52891 on NANCe Nerve-mediated Changes in Pulmonary Dynamics Evoked by Vagal Stimulation in the Guinea-pig. Pulmonary Pharmacology. 6(3). 201–208. 2 indexed citations

20.

Clapham, John C.. (1988). A Method for In Vivo Assessment of Calcium Slow Channel Blocking Drugs. Journal of Cardiovascular Pharmacology. 11(1). 56–60. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact